GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » EV-to-Revenue

Novomics Co (XKRX:283100) EV-to-Revenue : 13.27 (As of Jun. 09, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Novomics Co's enterprise value is ₩2,523.0 Mil. Novomics Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩190.1 Mil. Therefore, Novomics Co's EV-to-Revenue for today is 13.27.

The historical rank and industry rank for Novomics Co's EV-to-Revenue or its related term are showing as below:

XKRX:283100' s EV-to-Revenue Range Over the Past 10 Years
Min: 9.5   Med: 104.77   Max: 170.64
Current: 13.27

During the past 7 years, the highest EV-to-Revenue of Novomics Co was 170.64. The lowest was 9.50. And the median was 104.77.

XKRX:283100's EV-to-Revenue is ranked worse than
60.46% of 1037 companies
in the Biotechnology industry
Industry Median: 7.86 vs XKRX:283100: 13.27

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-09), Novomics Co's stock price is ₩628.00. Novomics Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩35.26. Therefore, Novomics Co's PS Ratio for today is 17.81.


Novomics Co EV-to-Revenue Historical Data

The historical data trend for Novomics Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co EV-to-Revenue Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - - - 94.95

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue Get a 7-Day Free Trial - - - - 94.95

Competitive Comparison of Novomics Co's EV-to-Revenue

For the Biotechnology subindustry, Novomics Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novomics Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novomics Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Novomics Co's EV-to-Revenue falls into.



Novomics Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Novomics Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2523.045/190.103
=13.27

Novomics Co's current Enterprise Value is ₩2,523.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novomics Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩190.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novomics Co  (XKRX:283100) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Novomics Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=628.00/35.263
=17.81

Novomics Co's share price for today is ₩628.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₩35.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novomics Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Novomics Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Novomics Co (XKRX:283100) Business Description

Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co (XKRX:283100) Headlines

No Headlines